Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 39Stomach Neoplasms 30Rectal Neoplasms 21Pancreatic Neoplasms 16Colonic Neoplasms 16Lymphoma, Large B-Cell, Diffuse 14Esophageal Neoplasms 13Adenocarcinoma Of Esophagus 12Carcinoma, Non-Small-Cell Lung 11Neoplasms 9Neoplasm Metastasis 9Adenocarcinoma 9Cholangiocarcinoma 7Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Biliary Tract Neoplasms 6Esophageal Squamous Cell Carcinoma 4Endometrial Neoplasms 4Carcinoma, Hepatocellular 4Lymphoma, Non-Hodgkin 3Lymphoma 3Lung Neoplasms 3Gastrointestinal Neoplasms 3Gallbladder Neoplasms 3Carcinoma 3Bile Duct Neoplasms 3Advanced Solid Tumors 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Spinocerebellar Degenerations 2

Interventions

pembrolizumab 2durvalumab 2Tretinoin 2Paclitaxel 2Oxaliplatin 2Irinotecan 2Chemoradiotherapy 2Carboplatin 2Capecitabine 2zanidatamab 1veliparib 1tucatinib 1trilaciclib 1trebananib 1trastuzumab duocarmazine 1tislelizumab 1tegafur-gimeracil-oteracil 1talazoparib 1sarilumab 1relugolix 1pexidartinib 1pertuzumab 1patritumab 1olaparib 1niraparib 1neratinib 1ganitumab 1enzalutamide 1dostarlimab 1cemiplimab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Pathologic Complete Response × Oxaliplatin × 90 days × Clear all
NCT07472868 2026-03-16

MEND-IT II

Catharina Ziekenhuis Eindhoven

Phase 3 Not yet recruiting
394 enrolled

Pathologic Complete Response

NCT06647680 2026-03-06

Neoadjuvant Chemotherapy and PD-1 Inhibitor for Locally Advanced Rectal Cancer(CONTROL-01)

The Affiliated Hospital of Qingdao University

Phase 2 Recruiting
35 enrolled
Gastrointestinal

Pathologic Complete Response, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡